Direct comparison of the clinical, immunological, and radiological parameters between the groups showed that, at baseline, seropositive patients exhibited significantly higher RF (P < 0.001) and ACPA (P = 0.01) values compared with seronegative RA subjects. The gene discussed is PRTN3; the disease is rheumatoid arthritis.